background: Polybrominated diphenyl ethers (PBDEs) are brominated flame retardants that have been defined as major environmental pollutants. While previous studies have found that PBDEs may enhance the levels of sex-steroid hormones, their effects on testosterone secretion from rat Leydig cells are unclear. This study investigated the effects and mechanisms of PBDE-710, a mixture of tetra-and penta-PBDEs, on testosterone biosynthesis in rat Leydig cells.
Introduction
Polybrominated diphenyl ethers (PBDEs), a class of flame retardants, have been used since 1960s (Siddiqi et al., 2003) . After polychlorinated biphenyls (PCBs), another class of flame retardants, were banned in 1977, PBDEs were established as the new major flame retardants (Vonderheide et al., 2008) . Now, they are widely used in a variety of housewares and electronic equipment, such as textiles, carpets, ceilings, air conditioning, electronic cables, computers, television sets and vehicles (Siddiqi et al., 2003) .
The chemical structure of PBDEs is composed of two phenyl rings connected by one oxygen atom. The other carbons might bind with various numbers of bromine residues at different positions. There are 209 possible types of PBDEs congeners, divided into 10 groups and numbered using the same system as the PCBs. The chemical structures of PBDEs are similar to those of PCBs and thyroid hormones (Fig. 1) .
Commercial PBDEs are marketed as one of three mixtures, known as penta-, octa-and deca-brominated BDE. PBDEs are generally used as either reactive or additive chemicals. Additive PBDEs, which are dissolved in the polymer, are easily leached into the environment and have been detected in work places (Sjodin et al., 1999 (Sjodin et al., , 2001 ) and indoor air (Gill et al., 2004) . After their release into the environment, PBDEs can be de-brominated, and become tetra-, penta-and hexa-BDEs. The less brominated congeners are more toxic, and bio-accumulate and bio-magnify in the food chain (Darnerud et al., 2001; Siddiqi et al., 2003; Hites, 2004) .
Although penta-, octa-and deca-PBDEs were recently banned in Europe and some states of North America, high concentrations of PBDEs still can be found in food, especially in fatty fish and meat (Schecter et al., 2008; Frederiksen et al., 2009 ). Mcdonald has demonstrated that the less brominated PBDEs predominate in human tissue, which usually accounts for 90% of the total body burden (McDonald, 2005; Costa and Giordano, 2007) . In addition, researchers have found an increasing concentration of PBDEs in human tissue and biota (Darnerud et al., 2001; Frederiksen et al., 2009) . Levels of PBDEs in breast milk and serum have increased in the past 20-30 years (Hooper and McDonald, 2000; Costa and Giordano, 2007) . Higher concentrations of serum PBDEs have also been observed in males with the ages of 15-24 when compared with older males (Thomsen et al., 2007) .
The effects of PBDEs on physiological functions have been well described in previous studies. PBDEs have been shown to alter thyroid hormone homeostasis and the nervous system, as well as gene expression in the liver of fetal rats (Carlson, 1980a,b; Fowles et al., 1994; Zhou et al., 2001; Darnerud et al., 2007; Suvorov and Takser, 2010) . Furthermore, effects of PBDEs on the male or female reproductive system have been reported in recent years (Stoker et al., 2005; Lilienthal et al., 2006; Gregoraszczuk et al., 2008) . On the basis of previous studies, PBDEs and their hydroxylated metabolites can affect steroidogenesis by up-regulating enzyme activities of aromatase (CYP19) and CYP17 (a cytochrome P450 enzyme that acts upon pregnenolone and progesterone to add a hydroxyl group at carbon 17 of the steroid D ring), and can influence the expression of some genes in H295R cells Song et al., 2008) . A positive correlation between plasma testosterone levels and BDE-47 has also been demonstrated (Turyk et al., 2008) . However, the action mechanism of PBDEs on steroidogenesis is still unclear. The direct actions of brominated biphenyl ethers on testicular function, especially on steroidogenesis in Leydig cells, are still obscure.
The aim of this study was to determine whether PBDE-710 exposures affect testosterone secretion and to investigate the mechanisms of such an effect. Because lower-bromined congeners are the dominant ones observed in organisms (de Wit et al., 2006) , we used PBDE-710, a mixture of tetra-and penta-PBDEs, to determine the effects of lower-bromined PBDEs on testosterone secretion in Leydig cells. As none of the established human Leydig cell lines available at present is able to synthesize testosterone (Payne and Hardy, 2007) , we used primary Leydig cells as a model.
Materials and Methods

Animals
Male Sprague-Dawley rats weighing 300 -350 g were housed in a temperature-controlled room (22 + 18C) with 14 h of artificial illumination daily (06:00 -20:00 h). Food and water were available ad libitum. The use of the animals was approved by the Institutional Animal Care and Use Committee of National Yang-Ming University. All animals received humane care in compliance with the Principles of Laboratory Animal Care and the Guide for the Care and Use of Laboratory Animals, published by the National Science Council, Taiwan, ROC.
Materials
Bovine serum albumin (BSA), HEPES, Hank's balanced salt solution, medium 199, sodium bicarbonate, penicillin-G, streptomycin sulfate, heparin, collagenase, human chorionic gonadotrophin (hCG), forskolin, 8-bromo-adenosine 3:5-cyclic monophosphate (8-Br-cAMP), 25-hydroxy-cholesterol (25-OH-C), pregnenolone, androstenedione, testosterone and SQ22536 were purchased from Sigma Chemical Co. (St. Louis, MO, USA). Trilostane (4,5-epoxy-17-hydroxy-3-oxoandrostane-2-carbonitrile), an inhibitor of 3b-hydroxysteroid dehydrogenase (3b-HSD), was provided by Sanofi-Synthelabo, Inc. (Malvern, PA, USA). 
Preparation of rat Leydig cells
Animals were sacrificed and the testes were collected and decapsulated. The testicular interstitial cells were isolated with the collagenase dispersion method as previously described Wu et al., 2010b) . The procedure used for the preparation of Leydig cells has been described elsewhere (Hsia et al., 2009; Wu et al., 2010a) . In brief, the testicular interstitial cells purified from rat testes were loaded onto the Percoll gradient and centrifuged at 48C, 800g for 30 min. The Leydig cells were located in a layer 3 -7 ml from the bottom. The Leydig cell layer was collected and suspended to 10 ml in incubation medium (1% BSA in Medium 199, with 25 mM HEPES, 2.2 g/ml NaHCO 3 , 100 IU/ml penicillin-G, 50 mg/ml streptomycin sulfate, 2550 USP U/l heparin, pH 7.4). The cell concentration and viability (over 95%) were determined by using a hemocytometer and the trypan blue method. To measure the abundance of Leydig cells in our preparation, the 3b-HSD staining method was used ( Wu et al., 2010a 1% BSA-M199 medium. After co-incubation with different stimulators for 1 h as indicated in the figure legends, 1 ml ice-cold PBSG (0.1% gelatinphosphate buffer saline, pH 7.5) was added to stop the reaction and the medium was centrifuged at 200g for 10 min. The supernatant was collected to measure the concentrations of testosterone by RIA and of pregnenolone and cAMP by enzyme-linked immunosorbent assay (ELISA).
Testosterone RIA
The concentrations of testosterone in media were determined by RIA, as previously described (Tsai et al., 2003; Hsia et al., 2009; Sergej et al., 2010) . The sensitivity of the testosterone RIA with anti-testosterone serum (No. W8) was 2 pg per assay tube. The intra-and inter-assay coefficients of variation were 4.1% (n ¼ 6) and 4.7% (n ¼ 10), respectively. There was no interference by PBDEs with testosterone assay (Supplementary data, Fig. S1 ).
ELISA of pregnenolone
The concentration of pregnenolone in the medium was determined by ELISA as previously mentioned (Wu et al., 2010b) . Highly purified pregnenolone (Sigma) was used as the standard. Standard or samples in combination with primary antibody (1:12 800 dilution in blocking buffer) were added into wells of the plates coated with pregnenolone -BSA and incubated at 378C for 1 h. After the incubation, the plates were washed and incubated with the conjugated secondary antibody (IgG-HRP, 1:5000 dilution in blocking buffer) at 378C for 30 min. After this incubation, the plates were washed with washing buffer. The plates were then incubated with the 3,3 ′ ,5,5 ′ -tetramethylbenzidine substrate (Sigma) under lightprotected conditions at room temperature for 10 min. Finally, 2 M HCl was applied to the plates to stop the reaction. The absorbance values were measured at 450 nm.
ELISA of cAMP
The intracellular levels of cAMP were measured in rat Leydig cells using a commercial ELISA kit (Assay Designs Inc.), as previous described (Hsia et al., 2007) . To study the accumulation of cAMP in response to PBDE-710, Leydig cells (1 × 10 5 cells/tube) were incubated with PBDE-710 (0, 0.5, 1.5, 5 and 15 ng/ml) in the presence or absence of hCG (0.05 IU/ml) or forskolin (10 25 M) for 1 h. At the end of incubation, cells were homogenized in 0.5 ml 65% ice-cold ethanol using a polytron homogenizer (PT-3000; Kinematica AG, Luzern, Switzerland) and then centrifuged at 2000g for 10 min. The cells were lysed in a vacuum concentrator (Speed Vac; Savant, Holbrook, NY, USA), and then reconstituted with assay buffer (0.05 M sodium acetate buffer containing 0.01% azide, pH 6.2) before measuring the concentration of cAMP by ELISA.
Western blot analysis
The method of western blotting has been described elsewhere (Chen et al., 2002; Chiao et al., 2002) . Leydig cells were incubated with or without PBDE-710 (0, 5 or 15 ng/ml) or hCG (0.05 IU/ml) for 1.5 h. The cells were then homogenized, proteins were separated by electrophoresis and electrotransferred to polyvinylidene difluoride membranes (NEN Life Science Products, Boston, MA, USA). The membrane was blocked in blocking buffer [Tris-buffered saline (TBS)-T buffer containing 5% non-fat dry milk]. These membranes were then incubated overnight with anti-protein kinase A a (PKAa) (1:1000, Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) and anti-SP3 (1:1000, Calbiochem, La Jolla, CA, USA). After washing with TBS-T buffer, the membranes were incubated for 1 h with horseradish peroxidase-conjugated goat anti-rabbit antibody (1:6000 dilution) in blocking buffer. The specific signals were detected by chemiluminescence (ECLTM western blotting detection reagents, Amersham Pharmacia Biotech, Buckinghamshire, UK). To avoid possible error during the exaction process, the nuclear PKAa protein level was normalized by the nuclear marker SP3. The cytoplasmic PKAa protein signal was corrected by b-actin signal.
Immunofluoresence assay
The detection of nuclear translocation of PKAa was modified from the procedure of a previous study . Rat Leydig cells (2 × 10 5 cells/ml; 10 5 cells/well) were seeded in 24-well plates with glass covers in an atmosphere of 5% CO 2 at 348C. After 2 days culture, Leydig cells were treated with hCG (0.05 IU/ml) or PBDE-710 (15 ng/ml) for different time courses (0, 5, 15, 30, 60, 90, 120 and 240 min) . At the end of the incubation, cells were fixed with 4% paraformaldehyde and permeabilized with 0.25% Triton X-100 at room temperature for 15 min. After blocking with 5% skim milk at 378C for 30 min, cells were incubated sequentially with PKAa antibody (1:50, Santa Cruz Biotechnology, Inc.) and 17b-HSD (1:50, Santa Cruz Biotechnology, Inc.) for 2 h, and with rhodamine-conjugated anti-rabbit IgG, fluorescein isothiocyanateconjugated anti-goat IgG (1:50, Jackson Immunolab, West Grove, PA, USA) plus 4 ′ ,6-diamidino-2-phenylindole (DAPI; 0.5 mg/ml; Sigma) in darkness at 378C for 1 h. Coverslips were then sealed onto the microscope slides using mounting solution. Fluorescence images were observed by confocal microscopy (Olympus IX-81; Olympus FV1000, Tokyo, Japan). Cells treated with hCG were used as a positive control.
Quantitative real-time polymerase chain reaction
Leydig cells (2 × 10 6 cells/well) were incubated with medium containing PBDE-710 (0, 1.5 or 15 ng/ml) or hCG (0.05 IU/ml) for 2 h. At the end of incubation, the cells were washed twice with DPEC saline and total RNA was isolated by TRIzol reagent (invitrogen, Carlsbad, CA, USA) as previously described (Hsia et al., 2007) . Total RNA used to define gene expression profiles was used in quantitative real-time polymerase chain reaction (Q-PCR) experiments following the instructions outlined in the LightCycler-RNA amplification kit SYBR Green I manual (Roche Molecular Biochemicals, Mannheim, Germany PBDEs effect on testosterone secretion
Statistical analysis
All values are given as mean + standard error of the mean (SEM). Analysis of variance (ANOVA) was used to examine the effects of PBDE-710 and different stimulators. The treatment means were tested for homogeneity by one-way ANOVA and the differences between specific means were tested for significance by Bonferroni's post hoc test (Steel and Torrie, 1980) . A difference between two means was considered statistically significant when P , 0.05 and highly significant when P , 0.01. 
05). (C)
Administration of high dosage of PBDE-710 (15 ng/ml) resulted in a significant increase in testosterone secretion (**P , 0.01). In contrast, administration of SQ22536, an adenylyl cyclase inhibitor, prevented PBDE-710-stimulated testosterone secretion. (D) Effects of PBDE-710 on cellular cAMP production by rat Leydig cells in response to hCG or forskolin. Cells were treated with different concentrations of PBDE-710 (0 -15 ng/ml) in the presence or absence of hCG (0.05 IU/ml) or forskolin (10 25 M), followed by an incubation for 1 h. Each column represents the mean + SEM.
*P , 0.05, **P , 0.01 when compared with the control group. ++ P , 0.01 when compared with the co-responding group.
Results
Effects of PBDE on basal and evoked secretion of testosterone in response to hCG, 8-Br-cAMP and forskolin
Effects of PBDEs on testosterone secretion in rat Leydig cells were examined. After 1-h incubation with varying concentrations of PBDE-710 (0.5 -15 ng/ml) in the presence or absence of hCG (0.05 IU/ml), 8-Br-cAMP or forskolin, the media were collected for the measurement of testosterone by RIA. Incubation of hCG, 8-Br-cAMP or forskolin, significantly increased testosterone secretion ( Fig. 2A , P , 0.01). PBDEs at a concentration of 5 or 15 ng/ml stimulated the basal level of testosterone and testosterone secretion caused by 8-Br-cAMP or forskolin but not by high concentrations of hCG in rat Leydig cells (n ¼ 5; P , 0.05 or P , 0.01; Fig. 2A ). To further evaluate the additive effect of PBDE-710 on testosterone release, a lower concentration of hCG (5 mIU/ml) was used. After co-incubation of PBDE (0.5 -15 ng/ml) and hCG (5 mIU/ml) for 1 h, the hCG-stimulated testosterone secretion was further elevated in the presence of the highest concentration of PBDE-710 (15 ng/ml) (n ¼ 5; P , 0.05; Fig. 2B ).
Effects of an adenylyl cyclase inhibitor on testosterone secretion induced by PBDE-710 in Leydig cells
To determine whether PBDE-710-stimulated testosterone secretion through cAMP pathway, an adenylyl cyclase inhibitor, SQ22536, was employed. After 1-h incubation of varying concentrations of PBDE-710 (0.5 -15 ng/ml) in the presence of SQ22536, the PBDE-stimulated testosterone secretion was prevented (Fig. 2C) . We suggest that PBDE-710-stimulated testosterone secretion by activating adenylyl cyclase activity.
Effects of PBDE-710 on the basal or evoked production of cAMP in Leydig cells
To confirm the aforementioned results, the cAMP levels in response to PBDEs in the presence or absence of hCG (0.05 IU/ml) or forskolin (10 25 M) were further studied. Leydig cells were incubated with PBDE-710 and hCG or forskolin for 1 h, and the generation of cellular cAMP was assessed by ELISA. Levels of the cellular cAMP extracted from Leydig cells were increased after administration of hCG and forskolin. Furthermore, PBDEs stimulated cellular cAMP in a dosedependent manner (P , 0.05 and P , 0.01). This phenomenon was also found in the forskolin treatment group. In contrast, PBDE failed to increase the cAMP levels induced by hCG at 0.05 IU/ml (Fig. 2D) .
Effects of PBDE-710 on the activity of CYP11A1 in rat Leydig cells
Since the activation of steroidogenic acute regulatory protein (StAR) and CYP11A1 play important roles in steroidogenesis (Evaul and Hammes, 2008) , we investigated whether the enzyme activity of CYP11A1 can be influenced by PBDE-710 treatment. Pregnenolone, the product of CYP11A1, was examined to determine the activity of CYP11A1 enzyme. Trilostane, an inhibitor of 3b-HSD, was used to block the production of progesterone. Rat Leydig cells were challenged with serial concentrations of 25-OH-C (0, 1, 3 and 10 mM) in the presence of trilostane (10 25 M). 25-OH-C increased pregnenolone secretion in the control group (P , 0.05, Fig. 3 ). PBDE-710 enhanced pregnenolone production in response to 25-OH-C in a dose-dependent manner (Fig. 3) .
Effects of PBDE-710 on PKAa nuclear translocation
To determine whether the PBDEs-induced cAMP production stimulated PKAa activation, nuclear translocation of PKAa was investigated by immunofluorence staining and western blotting. There was no PKAa translocation during the first 60 min treatment of hCG or PBDE-710 (data not shown). The results indicate that PBDE-710-stimulated PKAa nuclear translocation at 90 min (Fig. 4A) , and hCG-stimulated PKAa nuclear translocation at 60 and 90 min (Supplementary data, Fig. S2 and Fig. 4) . Moreover, nuclear translocation of PKAa was further examined after 90 min treatment with PBDE-710 in Leydig cells (Fig. 4B ). After treatment with PBDE-710 (15 ng/ml), the PKAa translocation was increased compared with the control group.
Effects of PBDE-710 on StAR gene expression
To confirm the aforementioned PKA nuclear translocation data, StAR gene expression was detected by Q-PCR. After 2 h treatment, StAR gene expression was also elevated by 2-and 4-fold after PBDE-710 (5 and 15 ng/ml) treatment, respectively (Fig. 4C) . In contrast, StAR PBDE-710 (5 or 15 ng/ml). The conversion of 25-OH-C to pregnenolone by CYP11A1 was measured by ELISA. In the absence of 25-OH-C, pregnenolone production was evoked by treatment with a high concentration of PBDE-710 (15 ng/ml). In the presence of 25-OH-C, the administration of PBDE-710 resulted in a higher activity of CYP11A1 than that in the vehicle group. Each sample was duplicated for pregnenolone measurement. *P , 0.05, **P , 0.01 when compared with the corresponding group. ++ P , 0.01 when compared with the control group.
PBDEs effect on testosterone secretion gene expression was elevated more than 5-fold after hCG (0.05 IU/ml) treatment.
Discussion
The present results demonstrate that PBDE-710 has a stimulatory effect on testosterone secretion in Leydig cells. PBDE-710 at the concentration of 15 ng/ml alone stimulated steroidogenesis in rat Leydig cells by elevating the cAMP production, increasing enzyme activity of CYP11A1, as well as by stimulating gene expression of StAR. In all species, the rate-limiting step for androgen biosynthesis includes the transfer of cholesterol by StAR protein from outer to inner mitochondrion membrane and conversion of cholesterol to pregnenolone by CYP11A1. StAR and CYP11A1 proteins are regulated by cAMP pathways (Evaul and Hammes, 2008) . In our present study, the additive effect of PBDE-710 was found after co-incubation with 8-Br-cAMP, forskolin ( Fig. 2A) or a low concentration of hCG but not in the co-administration of the higher concentration of hCG (Fig. 2B) . Moreover, when adenylyl cyclase was inhibited by SQ22536 administration, the stimulatory effect of PBDE-710 was abolished (Fig. 2C ). Intracellular cAMP concentration was also increased after administration of Leydig cells with higher concentrations of PBDE-710 (1.5, 5 and 15 ng/ml; Fig. 2D ). These results imply that PBDE-710 induces testosterone secretion through up-regulation of adenylyl cyclase activity. Stimulatory effects of PBDE-710 on cAMP levels and testosterone secretion were also observed in the presence of forskolin (Fig. 2D) . Interestingly, despite the production of hCG-induced cAMP, the stimulatory effect of PBDE-710 on cAMP levels was not observed in the hCG-induced group.
Additionally, we found an increase in activity of the CYP11A1 enzyme after PBDE-710 treatment (Fig. 3) . These results imply that PBDE-710 might elevate the formation of the complex of CYP11A1 and cholesterol to yield pregnenolone or stimulate the activity of CYP11A1 in situ in Leydig cells. These results further demonstrate that PBDE-710 stimulates testosterone secretion through stimulation upstream in the signaling pathway.
Nuclear translocation of PKAa was increased after 90 min of PBDE-710 (15 ng/ml) treatment and after 60 min of hCG (0.05 IU/ ml) treatment, as detected by immunofluorence and western blot assay ( Fig. 4A and B) . StAR mRNA expression is rapidly up-regulated in response to acute stimulation with trophic hormone and cAMP (Stocco, 2001) . We speculated that StAR mRNA might be regulated by PBDE-710 treatment. Stimulation of StAR gene expression was observed 2 h after PBDE-710 treatment (Fig. 4C) , and also in the hCG-treated group. In sum, these results indicate that the stimulatory effects of PBDE-710 on testosterone secretion are, at least in part, through stimulating cAMP production.
Regulation of mRNA levels of estrogen target genes by PBDE (BDE-99, subcutaneously injected at 1 or 10 mg/kg/day) was first demonstrated in the uterus in vivo (Ceccatelli et al., 2006) . Subsequent an in vivo study indicated that the subcutaneous injection with PBDE-710 (50 mg/kg/day) for 34 days has an estrogenic activity in the uterus (Mercado-Feliciano and Bigsby, 2008 PBDE-710 (15 ng/ml) significantly increased pregnenolone levels (Fig. 3) . This indicates that PBDE-710 causes either pregnenolone production by increasing the CYP11A1 activity or accumulation by inhibition of CYP17, or possibly both. A previous study also demonstrated that PBDEs inhibited the activity of 17a-hydroxylase/ 17,20-lyase cytochrome P450 (CYP17) in the human adrenal H295R cell line, which utilizes pregnenolone for 17a-hydroxypregnenolone (Cantó n et al., 2006) . However, Brock and Waterman (1999) found that rodent CYP17 has only 69% identical amino acid sequence with human CYP17, and catalyzes progesterone (P 4 ) more significantly than pregnenolone (P 5 ). Moreover, in our current study, we found PBDE-710 treatment increased testicular cAMP levels and activated PKA activity which could also increase CYP11A1 activity.
Previous studies have found that different congeners of BDEs or their metabolites can affect steroidogenesis in the H295R human adrenocortical carcinoma cell line. Along with the finding that 6-OH-2,2 ′ ,4,4 ′ -tetrabromoDE (6-OH-BDE47) and BDE-183 at concentrations of 10 mM inhibit activity of the CYP17 enzyme (Cantó n et al., 2006) , it has been demonstrated that the mRNA expression of CYP11B2 and the activity of aromatase as well as estradiol activity are inhibited by treatment with PBDEs metabolites . Moreover, StAR expression has also been enhanced by 6-OH-BDE-90 in H295R cell line (Song et al., 2008) . In our present study, testosterone release is elevated after PBDE treatment in primary Leydig cells. The mechanism is, at least in part, due to an increase of intracellular cAMP levels. Figure 5 Hypothetical scheme of PBDE-710 stimulation of testosterone secretion in rat Leydig cells. In the present study, we found that PBDE-710 stimulated the steroidogenesis pathway, at least in part, through stimulation of cAMP production. Generation of cAMP thus activates testosterone through several steps, including: (i) phosphorylation of EGFR and ERK, (ii) increase of CYP11A1 enzyme activities, (iii) PKA translocation into the nucleus, (iv) StAR gene expressions in rat Leydig cells. AC, adenylyl cyclase; StAR, steroidogenic acute regulatory protein; CYP11A1, cytochrome P450, family 11, subfamily A, polypeptide 1; +, PBDE-710 increased translocation of PKA into the nucleus.
PBDEs effect on testosterone secretion
The average level of serum PBDEs is about 5 ng/g lipid in Europe and Asia, and 200 ng/g lipid in North America (Costa et al., 2008) . A high concentration of PBDE was found in human breast milk (0.01-956 ng/g lipid) with a median range from 1.1 to 34.0 ng/g lipid, and the most prominent PBDE congeners were tetra-and penta-PBDEs (Costa and Giordano, 2007) . In this study, we used PBDE-710, a mixture of tetra-and penta-PBDEs, to determine the effects of PBDEs on testosterone secretion to mimic environmental human exposure. The concentrations of PBDE-710 used in the study ranged from 0.5 to 15 ng/ml, which was similar or greater than the median concentrations found in plasma and human breast milk.
In summary, the present results demonstrate that administration of PBDE-710 directly elevated cAMP production, and increased CYP11A1 enzyme activity and testosterone secretion in rat Leydig cells. In addition, the elevated cAMP level appears to have induced nuclear translocation of PKAa, thereby increasing StAR gene expression was increased (Fig. 5) . These findings provide further insights into the toxic effects of environmental chemicals on the endocrine system, effects on not only protein expression and/or activation of steroidogenic enzymes but also signal transduction by direct action on Leydig cells.
Conclusions
In conclusion, we have demonstrated that PBDE-710 can stimulate testosterone secretion. The stimulatory effect is, at least in part, due to the induction of the production of cAMP and the increase of CYP11A1 activity. These results imply that exposure to PBDEs has potential implications for testicular function and regulation in males.
